CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that more than 30,000 patients at high ...

CHELMSFORD, Mass.--(BUSINESS WIRE)-- ZOLL Medical Corporation (NASDAQ GS: ZOLL), a manufacturer of medical devices and related software solutions, today announced that physicians at all of the 17 ...

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NASDAQ GS: ZOLL), a manufacturer of medical devices and related software solutions, announced that a study demonstrating a reduction in ...

ESC Heart Failure Late Breaker: Largest single LifeVest® WCD study of NICM and MI/CAD patients shows high appropriate treatment rates during early period of contemporary GDMT CHELMSFORD, ...

Zoll Medical Corporation, which received FDA clearance a few years ago for both home and hospital versions of its wearable defibrillator LifeVest, is now dealing with a range of lawsuits and FDA ...

The US Food and Drug Administration (FDA) issued a safety alert today warning that the Zoll LifeVest 4000, a wearable cardioverter defibrillator, might not deliver a lifesaving shock due to a fault ...

Zoll Medical Corporation and Lifecor Inc have reached an exclusive distribution agreement for sales of the Lifecor LifeVest System to hospitals for inpatient use in the United States and Canada ...

LifeVest Wearable Defibrillator Prescribed by Physicians at All U.S. News and World Report’s #1 Ranked “Top Metro” Hospitals The LifeVest is worn by patients at risk for SCA, providing protection ...

ESC Heart Failure Late Breaker: Largest single LifeVest® WCD study of NICM and MI/CAD patients shows high appropriate treatment rates during early period of contemporary GDMT ZOLL®, an Asahi Kasei ...

ZOLL(R), an Asahi Kasei company that manufactures medical devices and related software solutions, announced results from SCD-PROTECT, a nationwide analysis of LifeVest(R) wearable cardioverter ...